Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KLF4 pseudogene 1 (KLF4P1) is a non-coding DNA element classified as a pseudogene of the Kruppel-like factor 4 (KLF4), a key transcription factor involved in cell proliferation, differentiation, apoptosis, and pluripotency[1][2][3][5][6][7]. Unlike its functional parent gene, KLF4P1 does not produce a protein product and has no documented physiological or pathological role. While some pseudogenes are occasionally implicated in gene regulation or as regulatory RNAs, there is no evidence in the current literature that KLF4P1 possesses such activity. Therefore, KLF4P1 is not regarded as a therapeutic target, disease gene, or biomarker. **Note:** All referenced functions and disease associations are linked to the parental KLF4 gene, not the pseudogene KLF4P1. Data on KLF4P1 itself are sparse, and its inclusion as a therapeutic target is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kruppel-like factor 4 pseudogene 1 (KLF4P1).